Similarly, upregulation of a key subunit of the PRC1 complex, BMI1, has been shown to favor the reprogramming toward a CSC phenotype through the repression of tumor suppressor pathways in tumor-initiating cells (254, 255). The gene discussed is BMI1; the disease is neoplasm.